Orthopaedic implant company 4WEB Medical has commercially introduced its Cervical Spine Plating Solution (CSTS-PS).
The company also intends to broaden its range of cervical products in the fourth quarter of this year, apart from introducing the new cervical plate.
This expansion will include an integrated anchor fixation system and a stand-alone integrated plate.
Offering various options for cervical fusion constructs to surgeons, both products will complement the presently available stand-alone cervical offering.
4WEB Medical spine division vice-president Geoff Bigos said: “By adding the CSTS-PS to 4WEB’s existing interbody device offering, the company continues to demonstrate its commitment to investing in further development of a comprehensive cervical portfolio.”
The company is engaged in the development of advanced implants that leverage Truss Implant Technology.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Its focus is on the development of Truss Implant designs for trauma, tumour and patient-specific applications.
The company’s product portfolio consists of the Anterior Spine Truss System, Cervical Spine Truss System, Lateral Spine Truss System, Posterior Spine Truss System, Stand Alone Anterior Spine Truss System and Stand Alone Cervical Spine Truss System.
4WEB Medical president Jessee Hunt said: “The launch of the CSTS-PS is a significant milestone for 4WEB.
“The company’s cervical portfolio is currently 4WEB’s fastest-growing product line and with the addition of cervical plating, anchor fixation and integrated plates, 4WEB will continue its rapid growth trajectory in 2023 and beyond.”